For prostate cancer, diagnostic approaches include prostate-specific antigen (PSA) blood tests, digital rectal exams (DRE), imaging (such as MRI), and confirmatory prostate biopsy [10]. The gene discussed is KLK3; the disease is prostate carcinoma.